The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...
The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero ...